The role of mismatch repair in DNA damage-induced apoptosis

Oncology Research

Volumn 11, Issue 9, 1999, Pages 393-400

  Li, Guo Min ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cancer; Genomic instability; Mismatch repair

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BACTERIAL PROTEIN; DNA BINDING PROTEIN; ESCHERICHIA COLI PROTEIN; MUTL PROTEIN, E COLI; MUTS PROTEIN, E COLI; PROTEIN MUTS; PROTEIN P53;

APOPTOSIS; CHEMISTRY; DNA DAMAGE; DNA REPAIR; DRUG RESISTANCE; GENETICS; HUMAN; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ADENOSINE TRIPHOSPHATASES; APOPTOSIS; BACTERIAL PROTEINS; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; DRUG RESISTANCE; ESCHERICHIA COLI PROTEINS; HUMANS; MUTS DNA MISMATCH-BINDING PROTEIN; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033290537     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (106)

1. Modrich, P. Mechanisms and biological effects of mismatch repair. Ann. Rev. Genet. 25:229-253; 1991.
2. Holmes, J.; Clark, S.; Modrich, P. Strand-specific mismatch correction in nuclear extracts of human and Drosophila mclanogasterccU lines. Proc. Natl. Acad. Sci. USA 87:5837-5841; 1990.
3. Umar, A.; Boyer, J. C.; Thomas, D. C.; Nguycn, D. C.; Risingcr, J. I.; Boyd, J.; lonov, Y.; Perucho, M.; Kunkel, T. A. Defective mismatch repair in extracts of colorcctal and cndonictrial cancer cell lines exhibiting microsatellite instability. J. Biol. Chem. 269: 14367-14370;1994.
4. 2-p!60 heterodimcr that restores DNA mismatch repair to tumor cells. Science 268:1909-1912; 1995.
5. Palombo, F.; Gallinari, P.; laccarino, I.; Lettieri, T.; Hughes, M.; D'Arrigo, A.; Truong, O.; Hsuan, J. J.; Jiricny, J. GTBP, a 160kilodalton protein essential for mismatch-binding activity in human cells. Science 268:1912-1914; 1995.
6. 2 and hMSH3, binds to insertion/deletion loops in DNA. Curr. Biol. 6:11811184; 1996.
7. Genschcl, J.; Littman, S. J.; Drummond, J. T.; Modrich, P. Isolation of MutSβ from human cells and comparison of the mismatch repair specificities of MutSβ and MutSa. J. Biol. Chcm. 273: 19895-19901; 1998.
8. 2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc. Natl. Acad. Sci. USA 93:13629-13634; 1996.
9. 2dependent mismatch repair. Genes Dev. 10:407-420; 1996.
10. 2. Curr. Biol. 6:484-486; 1996.
11. 2-MSH3-mediatcd mismatch recognition by the yeast MLH1-PMSI complex. Curr. Biol. 7:790-793; 1997.
12. 2-dependent gcnomic stability. J. Biol. Chem. 271:7285-7288; 1996.
13. Prolla, T. A.; Christie, D. M.; Liskay, R. M. Dual requirement in yeast DNA mismatch repair for MLHI and PMS1, two homologs of the bacterial mutL gene. Mol. Cell. Biol. 14:407-415; 1994.
14. Li, G. M.; Modrich, P. Restoration of mismatch repair to nuclear extracts of H6 colorcctal tumor cells by a heterodimcr of human MutL homologs. Proc. Natl. Acad. Sci. USA 92:1950-1954; 1995.
15. Flores-Rozas, H.; Kolodner, R. D. The Saccharomyccs ccrevisiae MLH3 gene functions in MSH3-dependcnt suppression of frameshift mutations. Proc. Natl. Acad. Sci. USA 95:12404-12409; 1998.
16. Raschle, M.; Marra, G.; Nystrom-Lahti, M.; Schar, P.; Jiricny, J. Identification of hMulLbcta, a heterodimer of hMLHl and hPMSl. J. Biol. Chem. 274:32368-32375; 1999.
17. Novvell, P. C. The clonal evolution of tumor cell populations. Science 194:23-28; 1976.
18. Loeb, L. A.; Springate, C. F.; Battula, N. Errors in DNA replication as a basis of malignant changes. Cancer Res. 34:2311 -2321 ; 1974.
19. Aaltonen, L. A.; Peltomaki, R; Mccklin, J. P.; Jarvinen, H.; Jass, J. R.; Grccn, J. S.; Lynch, H. T.; Watson, P.; Tallqvist, G.; Juhola. M.; Sistone, P.; Hamilton, S. R.; Kinzler, K. W.; Vogelstein, B.; de la Chapelle, A. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res. 54:1645-1648; 1994.
20. lonov, Y.; Peinado, M. A.; Malkhosyan. S.; Shibata, D.; Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonie carcinogcnesis. Nature 363: 558-561; 1993.
21. Thibodcau, S. N.; Brcn, G.; Schaid, D. Microsatellite instability in cancer of the proximal colon. Science 260:816-819; 1993.
22. Kinzler, K. W.; Vogclstein, B. Lessons from hereditär)' colorectal cancer. Cell 87:159-170; 1996.
23. de Wind, N.: Dekkcr, M.; Berns, A.; Radman, M.; te Rielc, H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrccombination, and predisposition to cancer. Cell 82:321-330; 1995.
24. 2 deficient mice are viable and susceptible to lymphoid tumours. Nat. Genet. 11:64-70; 1995.
25. Baker, S. M.; Plug, A. W.; Prolla, T. A.; Bronner, C. E.; Harris, A. C.; Yao, X.; Christie, D. M.; Moncll, C.; Arnhcim, N.; Bradley, A.; Ashlcy, T.; Liskay, R. M. Involvement of mouse Mlhl in DNA mismatch repair and rneiotic crossing over. Nat. Genet. 13:336-342; 1996.
26. Edelmann, W.; Cohcn, P. E.; Kanc, M.; Lau, K.; Morrow, B.; Bennctt, S.; Umar, A.; Kunkel, T.; Caltoretti, G.; Chaganti, R.; Pollard, J. W.; Kolodncr, R. D.; Kuchcrlapati, R. Meiotic pachylenc arrest in MLHI-deficient mice. Cell 85:1125-34; 1996.
27. Baker, S. M.; Bronncr, C. E.; Zhang, L.; Plug, A. W.; Robatzek, M.; Warren, G.; Elliott, E. A.; Yu, J.; Ashlcy. T.; Arnheim, N.; Flavell, R. A; Liskay, R. M. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82:309-319; 1995.
28. Fishel, R.; Kolodncr, R. D. Identification of mismatch repair genes and their role in the development of cancer. Curr. Opin. Genet. Dev. 5:382-395; 1995.
29. Modrich, P.; Lahue, R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 65:101-133; 1996.
30. Kolodner, R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 10:1433-1442; 1996.
31. Umar, A.; Kunkel, T. A. DNA-replication fidelity, mismatch repair and genome instability in cancer cells. Eur. J. Biochem. 238: 297-307; 1996.
32. Crose, G. Mismatch repair systems in Saccharomyces ccrevisiae. Totowa, NJ: Humana Press; 1997:411-448.
33. Jiricny, J. Eukaryotic mismatch repair: An update. Mutât. Res. 409:107-121; 1998.
34. Jiricny, J. Replication errors: Cha(lle)nging the genome. EMBO J. 17:6427-6436; 1998.
35. Kolodner, R. D.; Marsischky, G. T. Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev. 9:89-96; 1999.
36. Fram, R. J.; Cusick, P. S.; Wilson, J. M.; Marinus, M. G. Mismatch repair of m-diamminedichloroplatinum(II)-induced DNA damage. Mol. Pharmacol. 28:51-55; 1985.
37. Jones, M.; Wagner, R. A'-Mcthyl-W-nitro-A'-nitrosoguanidine sensitivity of E. coli mutants deficient in DNA methylation and mismatch repair. Mol. Gen. Genet. 184:562-563; 1981.
38. h-methylguaninc residues in E. coli DNA. Nature 296:868-869; 1982.
39. Goldmacher, V. S.; Cuzick, R. A.; Thilly, W. G. Isolation and partial characterization of human cell mutants differing in sensitivity to killing and mutation by methylnilrosourea and Nmethyl-W-nitro-nitrosoguanidine. J. Biol. Chem. 261:1246212471; 1986.
40. Kat, A.; Thilly. W. G.; Fang, W. H.; Longlcy, M. J.; Li, G. M.; Modrich, P. An alkylation-tolerant, imitator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA 90:6424-6428; 1993.
41. Papadopoulos, N.; Nicolaides, N. C.; Liu, B.; Parsons, R. E.; Palombo, F.; D'Arrigo, A.; Markowitz, S.; Willson, J. K. V.; Kinzler, K.; Jiricny, J.; Vogelstein, B. Mutations in GTBP in genetically unstable cells. Science 268:1914-1917; 1995.
42. Koi, M.; Umar, A.; Chauhan, D. P.; Cherian, S. P.; Carethers, J. M.; Kunkel, T. A.; Boland, C. R. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-mcthyl-N'-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLHl mutation. Cancer Res. 54: 4308-4312;1994.
43. Hawn, M. T.; Umar, A.; Carethers, J. M.; Marra, G.; Kunkel, T. A.; Boland, C. R.; Koi, M. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint. Cancer Res. 55:3721-3725; 1995.
44. Branch, P.; Aquilina, G.; Bignami, M.; Karran, P. Defective mismatch binding and a mutator phenolype in cells tolerant to DNA damage. Nature 362:652-654; 1993.
45. Aquilina, G.; Hess, P.; Branch, P.; MacGcoch, C.; Casciano, I.; Karran, P.; Bignami, M. A mismatch recognition defect in colon carcinoma confers DNA microsatellite instability and a mutator phenotype. Proc. Natl. Acad. Sci. USA 91:8905-8909; 1994.
46. Aquilina, G.; Hess, P.; Fiumicino, S.; Ceccotti, S.; Bignami, M. A mutator phenotype characterizes one of two complementation groups in human cells tolerant to methylation damaae. Cancer Res. 55:2569-2575; 1995.
47. Risinger, J. I.; Umar, A.; Barren, J. C.; Kunkel, T. A. A hPMS2 mutant cell line is defective in strand-specific mismatch repair. J. Biol. Chcm. 270:18183-18186; 1995.
48. 2 and HMSH6 in a human T-cell leukemia line tolerant to methylating agents. Genes Chromosomes Cancer 23:159-166; 1998.
49. Eastman, A. Characterization of the adduct produced in DNA by ci.T-diamminedichloroplatinum(ll) and a'i-dichloro(ethylenediamine)-platinum(II). Biochemistry 22:3927-3933; 1983.
50. Fichtinger-Schepman, A. M. J.; van Veer, J. L.; den Hartog, J. H.; Lohman, P. H.; Recdijk, J. Adducts of the antitumor drug ai-diamminedichloroplatinum(II) with DNA: Formation, identification, and quantitation. Biochemistry 24:707-713; 1985.
51. Drummond, J. T.; Anthoney, A.; Brown, R.; Modrich, P. Cisplatin and adriamycin resistance are associated with MutLa and mismatch repair deficiency in an ovarian tumor cell line. J. Biol. Chem. 271:19645-19648; 1996.
52. Anthoney, D. A.; Mclhvrath, A. J.; Gallaghcr, W. M.; F.dlin, A. R. M.; Brown, R. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res. 56: 1374-1381; 1996.
53. Aebi, S.; Kurdi-Haidar, B.; Gordon, R.; Cenni, B.; Zheng, H.; Fink, D.; Christen, R. D.; Boland, C. R.; Koi, M.; Fishel, R.; Howell, S. Loss of DNA mismatch repair in acquired resistance to cisplatin. Cancer Res. 56:3087-3090; 1996.
54. Fink, D.; Zheng, H.; Nebel, S.; Norris, P. S.; Aebi, S.; Lin, T. P.; Nehme, A.; Christen, R. D.; Haas, M.; MacLcod, C. L.; Howell, S. B. In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res. 57:1841-1845; 1997.
55. Fricdman, H. S.; Johnson, S. P.; Dong, Q.; Schold, S. C.; Rasheed, B. K.; Bigner, S. H.; Ali, O. F.; Dolan, E.; Colvin, O. M.; Houghton, P.; Germain, G.; Drummond, J. T.; Keir, S.; Marcelli, S.; Eigner, D. D.; Modrich, P. Mcthylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res. 57:2933-2936; 1997.
56. Fink, D.; Aebi, S.; Howell, S. B. The role of DNA mismatch repair in drug resistance. Clin. Cancer Res. 4:1-6; 1998.
57. D'Atri, S.; Tentori, L.; Lacal, P. M.; Graziani, G.; Pagani, E.; Benincasa, E.; Zambruno, G.; Bonmassar, E.; Jiricny, J. Involvement of the mismatch repair system in temozolomide-induced apoptosis. Mol. Pharmacol. 54:334-341; 1998.
58. Fritzell, J. A.; Narayanan, L.; Baker, S. M.; Bronner, C. E.; Andrew, S. E.; Prolla, T. A.; Bradley, A.; Jirik, F. R.; Liskay, R. M.; Glazer, P. M. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation. Cancer Res. 57:5143-5147; 1997.
59. Reitmair, A. H.; Risley, R.; Bristow, R. G.; Wilson, T.; Ganesh, A.; Jang, A.; Peacock, J.; Bcnchimol, S.; Hill, R. P.; Mak, T. W.; Fishel, R.; Meuth, M. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts. Cancer Res. 57:3765-71; 1997.
60. DcWeese, T. L.; Shipnian, J. M.; Larrier, N. A.; Buckley, N. M.; Kidd, L. R.; Groopman, J. D.; Cutler, R. G.; te Riele, H.; Nelson, W. G. Mouse embryonic stem cells carrying one or two defective Msh2 allcles respond abnormally to oxidative stress inflicted by low-level radiation. Proc. Natl. Acad. Sci. USA 95:11915-11920; 1998.
61. Wu, J.; Gu, L.; Geacintov, N. E.: Li, G.-M. Mismatch repair processing of carcinogen-DNA adducts triggers apoptosis. Mol. Cell. Biol. 19:8292-8301; 1999.
62. Duckett, D. R.; Drummond, J. T.; Murchie, A. I. II.; Reardon, J. T.; Sancar, A.; Lilley, D. M.; Modrich, P. Human MutSa recognizes damaged DNA base pairs containing O-4-methylguanine, O4-methyIthymine, or the cisplatin-d(GpG) adduct. Proc. Natl. Acad. Sci. USA 93:6443-6447; 1996.
63. Li, G.-M.; Wang, H.; Romano, L. J. Human MulSa specifically binds to DNA containing aminofluorene and acetylaminofluorene adducts. J. Biol. Chcm. 271:24084-24088; 1996.
64. Johnson, K. A.; Mierzwa, M. L.; Fink, S. P.; Marnett, L. J. MutS recognition of exocyclic DNA adducts that are endogenous products of lipid oxidation. J. Biol. Chcm. 274:27112-27118; 1999.
65. Rasmussen, L. J.; Samson, L. The Escherichia coli MutS DNA mismatch binding protein specifically binds Os-methylguanine DNA lesions. Carcinogenesis 17:2085-2088; 1996.
66. 2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chem. Biol. 3:579-589; 1996.
67. Mu, D.; Tursun, M.; Duckett, D. R.; Drummond, J. T.; Modrich, P.; Sancar, A. Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems. Mol. Cell. Biol. 17:760-769; 1997.
68. 2.MSH6 mismatch-repair protein heterodimers to DNA incorporating thymine- or uracil-containing UV light photoproducts opposite mismatched bases. J. Biol. Chem. 274:16894-16900; 1999.
69. 2 and MSH6 are required for removal of adenine misincorporated opposite 8oxo-guanine in S. cerevisiae. Mol. Cell 4:439-444; 1999.
70. Sancar, A. Excision repair in mammalian cells. J. Biol. Chem. 270:15915-15918; 1995.
71. Friedbcrg, E. C.; Walker, G. C; Siede, W. DNA repair and mutagenesis. Washington, DC: ASM Press; 1995.
72. Tominaga, Y.; Tsuzuki, T.; Shiraishi, A.; Kawate, H.; Sekiguchi, M. Alkylation-induced apoptosis of embryonic stem cells in which the gene for DNA-repair, methyltransferase, had been disrupted by gene targeting. Carcinogenesis 18:889-896; 1997.
73. Hickman, M. J.; Samson, L. D. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents. Proc. Natl. Acad. Sci. USA 96:10764-10769; 1999.
74. Toft, N. J.; Winton, D. J.; Kelly, J.; Howard, L. A.; Dckker, M.; te Riele, H.; Arends, M. J.; Wyllie, A. H.; Margison, G. P.; Clarke, A. R. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. Proc. Natl. Acad. Sci. USA 96:3911-3915; 1999.
75. Fujii, H.; Shimada, T. Isolation and characterization of cDNA clones derived from the divergently transcribed gene in the region upstream from the human dihydrofolate reductase gene. J. Biol. Chem. 264:10057-10064; 1989.
76. Watanabe, A.; Ikejima, M.; Suzuki, N.; Shimada, T. Genomic organization and expression of the human MSH3 gene. Genomics 31:311-318; 1996.
77. Drummond, J. T.; Genschel, J.; Wolf, E.; Modrich, P. DHFR/ MSH3 amplification in melhotrexate-resistant cells alters the hMutSo/hMutSβ ratio and reduces the efficiency of base-base mismatch repair. Proc. Natl. Acad. Sci. USA 94:10144-10149; 1997.
78. Marra, G.; laccarino, I.; Lettieri, T.; Roscilli, G.; Delmastro, P.; Jiricny, J. Mismatch repair deficiency associated with overexpression of the MSH3 gene. Proc. Natl. Acad. Sci. USA 95: 8568-8573; 1998.
79. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell 88:323-331; 1997.
80. Leonard, C. J.; Canman, C. E.; Kastan, M. B. The role of p53 in cell-cycle control and apoptosis: Implications for cancer. Philadelphia, PA: J. B. Lippincott; 1995:33-42.
81. Bunz, F.; Hwang, P. M.; Torrance, C.; Waldman, T.; Zhang, Y.; Dillchay, L.; Williams, J.; Lengaucr, C.; Kinzlcr, K. W.; Vogclslcin, B. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest. 104:263-269; 1999.
82. Xia. F.; Wane, X.; Wang, Y.; Tsang, N.; Yandcll, D. W.; Kelscy, K.; Liber, L. Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and upuptosis in two closely related human lymphoblast lines. Cancer Res. 55:12-15: 1995.
83. Bill. C. A.; Yu, Y.; Miselis, N. R.; Little, J. B.; Nickoloff. J. A. A role for p53 in DNA end rejoining by human cell extracts. Mutât. Res. 385:21-29; 1997.
84. Wyllie, A. IL; Kerr, J. F.; Curric, A. R. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68:251-306; 1980.
85. Wyllie, A. H. Cell death: A new classification separating apoptosis from necrosis. New York: Chapman and Hall; 1981:9-34.
86. Duckett, D. R.; Bronstcin, S. M.; Taya, Y.; Modrich, P. hMutSctand hMulLoc-dcpcndent phosphorylation of p53 in response to DNA mclhylator damage. Proc. Natl. Acad. Sci. USA 96:1238412388; 1999.
87. Canman, C. E.; Lim, D. S.; Cimprich, K. A.; Taya, Y.; Tamai, K.; Sakaguchi, K.; Appella, E.; Kastan, M. B.; Siliciano, J. D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677-1679; 1998.
88. Banin, S.; Moyal, L.; Shieh, S.; Taya, Y.; Andcrson, C. W.; Chessa, L.; Smorodinsky, N. L; Prives, C.; Reiss, Y.; Shiloh, Y.; Ziv, Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674-1677; 1998.
89. Wang, Y.; Eckhart, W. Phosphorylation sites in the amino-tcrminal region of mouse p53. Proc. Natl. Acad. Sci. USA 89:42314235; 1992.
90. Lees-Miller, S. P.; Sakaguchi, K.; Ullrich, S. J.: Appella. E.; Anderson, C. W. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-tcrminal transactivation domain of human p53. Mol. Cell. Biol. 12:5041-5049; 1992.
91. Araki, R.; Fukumura, R.; Fujimori, A.; Taya, Y.; Shiloh. Y.; Kurimasa. A.; Burma, S.; Li, G. C; Chen, D. J.: Sato, K.; Hoki, Y.; Tatsumi, K.; Abe, M. Enhanced phosphorylation of p53 serine 18 following DNA damage in DNA-dependent protein kinase catalytic subunit-deficient cells. Cancer Res. 59:3543-3546; 1999.
92. Burma, S.; Kurimasa, A.; Xie, G.; Taya. Y.; Araki, R.; Abe, M.; Crissman, H. A.; Ouyang, H.; Li, G. C.; Chen, D. J. DNA-dependent protein kinase-independent activation of p53 in response to DNA damage. J. Biol. Chem. 274:17139-17143; 1999.
93. McKendrick, L.; Milne, D.; Meek, D. Protein kinase CK2-dependent regulation of p53 function: Evidence that the phosphoryla-lion status of the serine 386 (CK2) site of p53 is constitutive and Mahle. Mol. Cell. Biochem. 191:187-199; 1999.
94. Hall, S. R.; Campbell, L. E.; Meek. D. W. Phosphorylation of p53 at the casein kinasc II site selectively regulates p53-dependent transcriptional repression hut not transactivation. Nucleic Acids Res. 24:1119-1126; 1996.
95. Delphin. C.; Huang, K. P.; Scotlo, C; Chapel, A.; Vincon, M.; Chamba/, E.; Garin, J.; Baudicr, J. The in vitro phosphorylation of p53 by calcium-dependent protein kinase C-characterization of a protein-kinase-C-binding site on p53. Eur. J. Biochem. 245: 684-692; 1997.
96. Lu, H.; Fisher, R. P.; Bailey, P.; Lcvine, A. J. The CDK7-cycH-p36 complex of transcription factor IIII phosphorylates p53, cnhancins its sequence-specific DNA bindina activity in vitro. Mol. Cell. Biol. 17:5923-5934; 1997.
97. Aquilina, G.; Ceccotti, S.; Martinclli, S.; Hampson, R.; Bignanii, M. N-(2-chlorocthyl)-N'-cyclohcxyl-N-nitrosourea sensitivity in mismatch repair-defective human cells. Cancer Res. 58:135-141; 1998.
98. Klingelhut/, A. J.; Foster, S. A.; McDougall, J. K. Telomcrase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79-82; 1996.
99. Gong, J. G.; Costanzo, A.; Yang, H. Q.; Melino, G.; Kaelin, W. G., Jr.; Lcvrcro, M.; Wang, J. Y. The tyrosinc kinase c-Abl regulates p73 in apoptotic response to cisplatin-induccd DNA damage. Nature 399:806-809; 1999.
100. Karran, P.; Bignanii, M. DNA damage tolerance, mismatch repair and genome instability. Biocssays 16:833-839; 1994.
101. Modrich, P. Strand-specific mismatch repair in mammalian cells. J. Biol. Chem. 272:24727-24730; 1997.
102. Jost, C. A.; Marin, M. C.; Kaelin, W. G., Jr. p73 is a human p53-rclated protein that can induce upoplosis. Nature 389:191-194; 1997.
103. Sancar, A. Mechanisms of DNA excision repair. Science 266: 1954-1956; 1994.
104. Bcn-Yehuda, D.; Krichevsky, S.; Caspi, O.; Rund, D.; Polliack, A.; Abeliovich, D.; Zelig, O.; Yahalom, V.; Paltiel, O.; Or. R.; Perelz, T.; Ben-Neriah, S.; Ychuda, O.; Rachmilewitz, E. A. Microsatcllite instability and p53 mutations in therapy-related leukemia suggest mutator phcnotype. Blood 88:4296-4303; 1996.
105. Suann, P~. Fv, Waters, T. R.; Moulton, D. C.; Xu, Y. Z.; Zheng. Q.; Edwards, M.; Mace, R. Role of postrcplicalion DNA mismatch repair in the cytotoxic action of thioguanine. Science 273: 1109-1111; 1996.
106. Yamada, M.; O'Regan, E.; Brown, R.; Karran, P. Selective recognition of a cisplatin DNA adduct by human mismatch repair proteins. Nucleic Acids Res. 25:491-496; 1997.